Tuesday, January 31, 2023
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Cancer

Neurofeedback reduces pain, increases quality of life for cancer patients suffering from chemotherapy-induced neuropathy

March 14, 2016
in Cancer
0
Share on FacebookShare on Twitter
IMAGE

A new study from The University of Texas MD Anderson Cancer Center evaluating the use of neurofeedback found a decrease in the experience of chronic pain and increase quality of life in patients with neuropathic pain.

The study will be presented at the annual meeting of the American Psychosomatic Society, held March 9-12 in Denver, Colorado.

Study lead investigator Sarah Prinsloo, Ph.D., assistant professor Palliative, Rehabilitation, and Integrative Medicine at MD Anderson, identified the location of brain activity that contributes to the physical and emotional aspects of chronic pain, which allowed patients to modify their own brain activity through electroencephalogram (EEG) biofeedback. EEG tracks and records brain wave patterns by attaching small metal discs with thin wires on the scalp, and then sending signals to a computer to record the results.

"Chemotherapy-induced peripheral neuropathy is very common in cancer patients and there is currently only one medication approved to treat it. I'm encouraged to see the significant improvements in patient's quality of life after treatment. This treatment is customized to the individual, and is relatively inexpensive, non-invasive and non-addictive." Prinsloo said.

Chronic chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of chemotherapy, often affecting 71 to 96 percent of patients after a month of chemotherapy treatment. Peripheral neuropathy is a set of symptoms such as pain, burning, tingling and loss of feeling caused by damage to nerves that control the sensations and movements of our arms and legs.

Neuroplasticity is the ability of the brain to form new connections and change existing ones. This study demonstrated that neurofeedback induces neuroplasticity to modulate brain activity and improve CIPN symptoms.

The study enrolled 71 MD Anderson patients of all cancer types; all were at least 3 months post chemotherapy treatment and reported more than a three on the National Cancer Institute's neuropathy rating scale. Study participants completed assessments that determined the brain activity related to their pain, pain perception and quality of life. Those were then randomized to receive neurofeedback, or to a control group that did not receive treatment. Patients in the neurofeedback group attended 20 sessions of neurofeedback training where they played a computer game that rewarded them when they modified their brainwave activity in the affected area. They then learned to modify the activity without an immediate reward from the game.

After treatment was completed the participants repeated the EEG and assessments to determine changes in pain perception, cancer related symptoms and general quality of life. EEG patterns showed cortical activity characterized by increased activation in the parietal and frontal sites compared to a normal population. After controlling for baseline levels, neurofeedback significantly reduced: pain; numbness; intensity and unpleasantness, and reduced how much pain interfered with daily activities.

After treatment, 73 percent saw improvement in their pain and quality of life. Patients with CIPN also exhibited specific and predictable EEG signatures that changed with neurofeedback.

Prinsloo believes the study results are clinically and statistically significant and provides valuable information that will allow for more understanding of neuropathic pain.

A second study was recently funded and will focus exclusively on breast cancer patients experiencing neuropathy.

###

In addition to Prinsloo, authors include: Jennifer McQuade, M.D., Diane Novy, Ph.D., Larry Driver, M.D., Lois Ramondetta, M.D., Cathy Eng, M.D., Gabriel Lopez, M.D., Richard Lee, M.D., Lorenzo Cohen, Ph.D., of MD Anderson and Randall Lyle, Ph.D., Mount Mercy University, Cedar Rapids.

This study was funded by the American Cancer Society (PF-11-169-01-PCSM), National Center for Complementary and Integrative Health (1K01AT008485-01), and the Hille Foundation.

Media Contact

Lany Kimmons
[email protected]
713-563-5801
@mdandersonnews

http://www.mdanderson.org

Share25Tweet16Share4ShareSendShare
  • blank

    Null results research now published by major behavioral medicine journal

    545 shares
    Share 218 Tweet 136
  • New study shows snacking on mixed tree nuts may impact cardiovascular risk factors and increase serotonin

    127 shares
    Share 51 Tweet 32
  • Cambridge-led consortium receives $35m to boost crop production sustainably in sub-Saharan Africa

    65 shares
    Share 26 Tweet 16
  • This groundbreaking biomaterial heals tissues from the inside out

    65 shares
    Share 26 Tweet 16
  • New analogue quantum computers to solve previously unsolvable problems

    64 shares
    Share 26 Tweet 16
  • Almost all of Africa’s maize crop is at risk from devastating fall armyworm pest, study reveals

    64 shares
    Share 26 Tweet 16
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

New study shows snacking on mixed tree nuts may impact cardiovascular risk factors and increase serotonin

Null results research now published by major behavioral medicine journal

Hydrogen peroxide from tea and coffee residue: New pathway to sustainability

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 205 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In